Publicaciones (32) Publicaciones de ÁLVARO GUTIÉRREZ UZQUIZA

2024

  1. CRISPR/Cas9 screenings unearth protein arginine methyltransferase 7 as a novel essential gene in prostate cancer metastasis

    Cancer Letters, Vol. 588

  2. Genomic and Immunologic Correlates in Prostate Cancer with High Expression of KLK2

    International Journal of Molecular Sciences, Vol. 25, Núm. 4

2023

  1. Germline gain-of-function MMP11 variant results in an aggressive form of colorectal cancer

    International Journal of Cancer, Vol. 152, Núm. 2, pp. 283-297

  2. New and Old Key Players in Liver Cancer

    International Journal of Molecular Sciences, Vol. 24, Núm. 24

2022

  1. C3G down-regulation enhances pro-migratory and stemness properties of oval cells by promoting an epithelial-mesenchymal-like process

    International journal of biological sciences, Vol. 18, Núm. 15, pp. 5873-5884

  2. In vivo production of fluorine-18 in a chicken egg tumor model of breast cancer for proton therapy range verification

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. C3G downregulation induces the acquisition of a mesenchymal phenotype that enhances aggressiveness of glioblastoma cells

    Cell Death and Disease, Vol. 12, Núm. 4

  2. C3G protein, a new player in glioblastoma

    International Journal of Molecular Sciences, Vol. 22, Núm. 18

  3. Cancer-associated fibroblasts in breast cancer treatment response and metastasis

    Cancers, Vol. 13, Núm. 13

  4. Centrosome dynamics and its role in inflammatory response and metastatic process

    Biomolecules, Vol. 11, Núm. 5

  5. Contribution of c3g and other gefs to liver cancer development and progression

    Hepatoma Research, Vol. 7

  6. Direct proton range verification using oxygen-18 enriched water as a contrast agent

    Radiation Physics and Chemistry, Vol. 182

  7. HGK promotes metastatic dissemination in prostate cancer

    Scientific Reports, Vol. 11, Núm. 1

  8. NAC blocks Cystatin C amyloid complex aggregation in a cell system and in skin of HCCAA patients

    Nature Communications, Vol. 12, Núm. 1

2020

  1. Biological and Mechanical Synergies to Deal With Proton Therapy Pitfalls: Minibeams, FLASH, Arcs, and Gantryless Rooms

    Frontiers in Oncology, Vol. 10

  2. C3G is upregulated in hepatocarcinoma, contributing to tumor growth and progression and to HGF/MET pathway activation

    Cancers, Vol. 12, Núm. 8, pp. 1-22

2019

  1. ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitor

    Nature Medicine, Vol. 25, Núm. 7, pp. 1116-1122

  2. RUNX proteins desensitize multiple myeloma to lenalidomide via protecting IKZFs from degradation

    Leukemia, Vol. 33, Núm. 8, pp. 2006-2021

2018

  1. Pathogenic variant in EPHB4 results in central conducting lymphatic anomaly

    Human Molecular Genetics, Vol. 27, Núm. 18, pp. 3233-3245

2016

  1. C3G knock-down enhances migration and invasion by increasing Rap1-mediated p38α activation, while it impairs tumor growth through p38α-independent mechanisms

    Oncotarget, Vol. 7, Núm. 29, pp. 45060-45078